FIELD: biotechnology.
SUBSTANCE: isolated antibodies or their antigen-binding fragments, that specifically bind toxin B and/or A of C. difficile, are described. Also, compositions and kits containing such antibodies are provided. Hybridoma cell lines deposited under access numbers ATCC PTA-9693, ATCC PTA-9692, ATCC PTA-9694, ATCC PTA-9888, where hybridoma produces a monoclonal antibody that specifically binds the toxin of C. difficile, are presented.
EFFECT: invention expands the arsenal of tools for inhibition or neutralisation of toxicity caused by said toxin.
50 cl, 42 dwg, 8 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS RELATED TO CLOSTRIDIUM DIFFICILE MUTANT TOXIN, AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2592686C2 |
| METHOD OF PRODUCING AMINO ACID SEQUENCES CODING NANOANTIBODIES NEUTRALIZING CLOSTRIDIOIDES DIFFICILE A TOXIN | 2023 |
|
RU2833930C1 |
| ANTIKINE ANTIBODIES BINDING TO SEVERAL CC-CHEMOKINES | 2010 |
|
RU2574786C2 |
| MONOCLONAL ANTIBODIES TO CD44, INTENDED FOR USE IN TREATING SQUAMOUS CELL CARCINOMA OF THE HEAD AND THE NECK | 2011 |
|
RU2599447C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS | 2015 |
|
RU2636780C1 |
| COMPOSITIONS AND METHODS RELEVANT TO MUTANT TOXIN FROM CLOSTRIDIUM DIFFICILE | 2013 |
|
RU2630671C2 |
| ANTIBODIES FOR SPECIFIC BINDING OF STAPHYLOCOCCUS AUREUS ALPHA-TOXIN AND METHODS OF APPLICATION | 2012 |
|
RU2620065C2 |
| IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USING | 2006 |
|
RU2444528C2 |
| METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2671481C2 |
| MONOCLONAL ANTIBODIES AGAINST INTERFERON-ALPHA AND APPLICATION METHODS | 2006 |
|
RU2431638C2 |
